FORCE FOREVER supplement tablets recalled for undisclosed drugs
GNMart LLC is recalling FORCE FOREVER 400mg tablets nationwide after the FDA found the product contains undisclosed Diclofenac and Dexamethasone. The Class I recall affects all lots of this dietary supplement product.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This product received an FDA Class I drug recall classification due to contamination with undisclosed pharmaceutical drugs (Diclofenac and Dexamethasone) in a product marketed as a dietary supplement. No reported illnesses or deaths are documented in the available information.
Plain-English summary
GNMart LLC is recalling FORCE FOREVER 400mg Tablets across the United States. The product is sold in 60-count bottles and marketed as a dietary supplement (SUPLEMENTO ALIMENTICIO).
The FDA determined that the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). FDA analysis found the product to be tainted with Diclofenac and Dexamethasone.
The recall affects 374 bottles distributed nationwide. All lots are subject to the recall, with an expiration date of March 27, 2030.
Consumers who have purchased this product should stop using it immediately and consult a healthcare provider if they have taken the product and experience any adverse effects.
The recalled product
- Product
- FORCE FOREVER 400mg Tablets, Huesos y articulaciones sin dolor, SUPLEMENTO ALIMENTICIO, 60-count bottles
- Manufacturer
- GNMart LLC
- Category
- Drug — Dietary Supplement
- Hazard
- unapproved-drugs
- diclofenac
- dexamethasone
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- All lots
- Exp. Date: 03/27/2030
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27